| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |